跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MDK-NITISINONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MDK-NITISINONE
Authorized
STANDARD
MDK-NITISINONE
Mendelikabs Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8d5680b372d82e0b
Company
Mendelikabs Inc.
Type
Standard
Approval Details
Approval Id
8d5680b372d82e0b
Drug Approval Canada Name
MDK-NITISINONE
Product Name
MDK-NITISINONE
Status
Dormant
Status Date
2020-06-24
Original Market Date
2019-02-01
Din
02470055
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:92.00
Atc Original
A16AX04 NITISINONE
Atc Name
a 16 ax 04
Aig Number
0158450004
Company Name
Mendelikabs Inc.
Company Address
4601 Rue Tonnancour, St Hubert, Quebec, Canada, J3Y 9J3
Company Detail Path
/organization/mendelikabs-inc
Company Information
Pharmaceutical Company Name
Mendelikabs Inc.
Country Name
Canada
Province Name
Quebec
City Name
saint-hubert,quebec,country_ca
Address
4601 rue de Tonnancour
Active Ingredients
NITISINONE
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8d5680b372d82e0b
Type
Standard
Back to Health Canada Approvals